Smart patches track vital signs in dying patients to improve End-of-Life care

NCT ID NCT07512505

Recruiting now Knowledge-focused Sponsor: Our Lady's Hospice and Care Services Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether wearable devices that monitor heart rate and other vital signs can help doctors and nurses spot infections and other problems earlier in hospice patients with advanced cancer. The researchers will also see if these measurements can help predict how long a person has to live. The study involves 120 adults admitted for end-of-life care, who will wear a small ECG patch for up to 14 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help hospice staff spot infections earlier and improve comfort for dying patients. It may also lead to better predictions of how long a person has to live.
What could go wrong: This is a small, early-stage observational study with only 120 participants. The findings may not apply to all patients, and the wearable patches might be uncomfortable or cause skin irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER HOSPICE MALIGNANCIES MULTIPLE TERMINAL CARE

Contacts and locations

Locations

Our Lady's Hospice and Care Services
RECRUITING

Dublin, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.